Methodology Checklist 1: Systematic Reviews and Meta-
SIGN analyses
SIGN gratefully acknowledges the permission received from the authors of the AMSTAR tool to base
this checklist on their work: Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C,. et
al. Development of AMSTAR: a measurement tool to assess the methodological quality of
systematic reviews. BMC Medical Research Methodology 2007, 7:10 doi:10.1186/1471-2288-7-10.
Available from http://www.biomedcentral.com/1471-2288/7/10 [cited 10 Sep 2012]
Study identification (Include author, title, year of publication, journal title, pages)
Guideline topic: Key Question No:
Before completing this checklist, consider:
Is the paper relevant to key question? Analyse using PICO (Patient or Population
Intervention Comparison Outcome). IF NO reject. IF YES complete the checklist.
Checklist completed by:
Section 1: Internal validity
In a well conducted systematic review: Does this study do it?
1.1 The research question is clearly defined and the
inclusion/ exclusion criteria must be listed in the Yes □ No □
paper. If no reject
1.2 A comprehensive literature search is carried out. Yes □ No □
Not applicable
□
If no reject
1.3 At least two people should have selected Yes □ No □
studies.
Can’t say □
1.4 At least two people should have extracted data. Yes □ No □
Can’t say □
1.5 The status of publication was not used as an Yes □ No □
inclusion criterion.
1.6 The excluded studies are listed. Yes □ No □
1.7 The relevant characteristics of the included Yes □ No □
studies are provided.
1.8 The scientific quality of the included studies was Yes □ No □
assessed and reported.
1.9 Was the scientific quality of the included studies Yes □ No □
used appropriately?
1.10 Appropriate methods are used to combine the Yes □ No □
individual study findings.
Can’t say □ Not applicable
□
1.11 The likelihood of publication bias was assessed
appropriately. Yes □ No □
Not applicable
□
1.12 Conflicts of interest are declared. Yes □ No □
SECTION 2: OVERALL ASSESSMENT OF THE STUDY
2.1 What is your overall assessment of the High quality (++) □
methodological quality of this review?
Acceptable (+) □
Low quality (-)□
Unacceptable – reject 0 □
2.2 Are the results of this study directly applicable to Yes □ No □
the patient group targeted by this guideline?
2.3 Notes: